Search research articles
Contact Us
Filters
Showing results (361-370 of 373) with videos related to
Page
of 38
Sort By:
JCO Oncology Practice
|
July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach
Jennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2020
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Cesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
Alice Y Ho, Jean L Wright, Rachel C Blitzblau, et al.
Cancer Discovery
|
October 4, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, et al.
Biology
|
October 10, 2020
Clinical Veterinary Boron Neutron Capture Therapy (BNCT) Studies in Dogs with Head and Neck Cancer: Bridging the Gap between Translational and Clinical Studies
Amanda E Schwint, Andrea Monti Hughes, Marcela A Garabalino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Nature Medicine
|
October 19, 2023
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
Jason J Luke, Manish R Patel, George R Blumenschein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R A Freedman, H M Heiling, T Li, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 373) with videos related to
Sort By:
Page
of 38
JCO Oncology Practice
|
July 1, 2020
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach
Jennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2020
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Cesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2021
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
Jarushka Naidoo, Karisa C Schreck, Wei Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2020
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
Alice Y Ho, Jean L Wright, Rachel C Blitzblau, et al.
Cancer Discovery
|
October 4, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, et al.
Biology
|
October 10, 2020
Clinical Veterinary Boron Neutron Capture Therapy (BNCT) Studies in Dogs with Head and Neck Cancer: Bridging the Gap between Translational and Clinical Studies
Amanda E Schwint, Andrea Monti Hughes, Marcela A Garabalino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M Tung, Mark E Robson, Steffen Ventz, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Nature Medicine
|
October 19, 2023
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
Jason J Luke, Manish R Patel, George R Blumenschein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R A Freedman, H M Heiling, T Li, et al.
Page
of 38